TABLE 1.
Potential binding sitea | Avg free energy (ΔG) ± SDb
|
|
---|---|---|
CRK SH2 | CRKL SH2 | |
FGFR1 autophosphorylation sites | ||
pY463 (GVSEpYELPEDPRWELPR) | −231.44 ± 21.90 | −343.99 ± 32.63 |
pY583/pY585 (PGLEpYCpYNPSHNPEEQLSS) | −113.38 ± 39.06 | −220.74 ± 27.41 |
pY653/pY654* (HHIDpYpYKKTTNGRLPVKW) | ND | ND |
pY730 (TNELpYMMMRDCWHAVPS) | −268.08 ± 29.44 | −379.22 ± 18.95 |
pY766 (SNQEpYLDLSMPLDQYSP) | −167.49 ± 24.39 | −247.40 ± 17.28 |
CRK/CRKL internal sites | ||
p221 in CRK (EPGPpYAQPSVNTPLPNL) | −262.85 ± 39.02 | ND |
p207 in CRKL (PAHApYAQPQTTTPLPAV) | ND | −268.40 ± 13.56 |
Amino acid sequences used for simulation are given in single-letter code in parentheses; pY (indicated in boldface) denotes a phosphotyrosine. *, Y653/Y654 locate within the activation loop of the catalytic domain and are therefore omitted in the current analysis.
The values are shown as averages from structures extracted every 10 ps between 4 and 5 ns of simulations in kcal/mol. ND, not determined.